Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2018 | EHA 2018 VJHemHeroes Winner – Abdul Naser Nourallah

Abdul Naser Nourallah • 14 Jun 2018
EHA 2018
Multiple Myeloma Daratumumab

EHA 2018 VJHemHeroes winner Abdul Naser Nourallah, MD, from Almana General Hospital, Khobar, Saudi Arabia, passionately discusses what he believes to be a major advancement in the treatment of multiple myeloma (MM). As a result of novel, successful therapies being introduced in the field of MM, he highlights how we are moving away from transplant and predicts that it may be delayed or not needed in the future. This interview was recorded at the 23rd congress of the European Haematology Association (EHA) 2018, held in Stockholm, Sweden.

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals